Otoprotection
Showing 1 - 9 of 9
Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)
Recruiting
- Ototoxicity, Drug-Induced
- Sodium Thiosulfate
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 6, 2023
Hepatoblastoma Trial in Shanghai (Sodium Thiosulfate Injection, Primary surgery resection, mono CDDP-Group A2)
Recruiting
- Hepatoblastoma
- Sodium Thiosulfate Injection
- +10 more
-
Shanghai, Shanghai, ChinaShanghai Children's Medical Center
Jul 23, 2022
Aging Trial in Sugar Land (AC-11)
Active, not recruiting
- Aging
- AC-11
-
Sugar Land, TexasThrive Medicine Clinic
Apr 8, 2022
Neuroectodermal Tumors, Primitive, Liver Tumors, Osteosarcoma Trial in Los Angeles (N-Acetylcysteine)
Completed
- Neuroectodermal Tumors, Primitive
- +3 more
-
Los Angeles, CaliforniaChildrens Hospital Los Angeles
Apr 28, 2022
Cancer Trial in Philadelphia (procedure, drug, other)
Terminated
- Cancer
- Insertion of Pressure Equalization (PE) Tubes
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Sep 15, 2017
Temporary Auditory Threshold Shift Trial in Gainsville (SPI-1005 Low dose, SPI-1005 Middle dose, SPI-1005 High dose)
Completed
- Temporary Auditory Threshold Shift
- SPI-1005 Low dose
- +3 more
-
Gainsville, FloridaUniversity of Florida
Aug 26, 2014
Cisplatin, Ototoxicity, Intratympanic Steroids Trial in Safed (Intra-tympanic Cisplatinum)
Unknown status
- Cisplatin
- +2 more
- Intra-tympanic Cisplatinum
-
Safed, IsraelZiv Medical Center
Jan 27, 2011
Hearing Loss Trial in Montreal (Ringer's Lactate (0.03% Ciprofloxacin))
Unknown status
- Hearing Loss
- Ringer's Lactate (0.03% Ciprofloxacin)
-
Montreal, Quebec, CanadaMontreal General Hospital
Apr 20, 2010
Ototoxicity, Hearing Loss Trial in BrasÃlia (Ginkgo Biloba Extract (GBE761), Placebo)
Completed
- Ototoxicity
- Hearing Loss
- Ginkgo Biloba Extract (GBE761)
- Placebo
-
BrasÃlia, DF, BrazilHospital de Base do Distrito Federal (HBDF)
Jun 7, 2010